PL126234B1 - Process for preparing novel octahydropyrazolo-/3,4-g/-quinolines - Google Patents
Process for preparing novel octahydropyrazolo-/3,4-g/-quinolines Download PDFInfo
- Publication number
- PL126234B1 PL126234B1 PL1979231121A PL23112179A PL126234B1 PL 126234 B1 PL126234 B1 PL 126234B1 PL 1979231121 A PL1979231121 A PL 1979231121A PL 23112179 A PL23112179 A PL 23112179A PL 126234 B1 PL126234 B1 PL 126234B1
- Authority
- PL
- Poland
- Prior art keywords
- trans
- compounds
- mixture
- formula
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US506179A | 1979-01-22 | 1979-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL126234B1 true PL126234B1 (en) | 1983-07-30 |
Family
ID=21713955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1979231121A PL126234B1 (en) | 1979-01-22 | 1979-06-29 | Process for preparing novel octahydropyrazolo-/3,4-g/-quinolines |
Country Status (8)
Country | Link |
---|---|
JP (2) | JPS55100387A (en, 2012) |
KR (1) | KR840002068B1 (en, 2012) |
AT (1) | AT372947B (en, 2012) |
BE (1) | BE877327A (en, 2012) |
CS (3) | CS227009B2 (en, 2012) |
HU (2) | HU180234B (en, 2012) |
PL (1) | PL126234B1 (en, 2012) |
SU (3) | SU1360586A3 (en, 2012) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59222477A (ja) * | 1983-05-31 | 1984-12-14 | イーライ・リリー・アンド・カンパニー | トランス−dl−1−アルキル−6−アルコキシオクタヒドロキノリン |
US5472998A (en) * | 1994-09-16 | 1995-12-05 | E. I. Du Pont De Nemours And Company | Polymeric additive for cathodic electrocoating compositions for improved throw power |
JP2000505046A (ja) * | 1995-08-18 | 2000-04-25 | パーデュー・リサーチ・ファウンデーション | ドーパミン受容体リガンドとしての新規の融合イソキノリン類 |
-
1979
- 1979-06-26 HU HU79EI864A patent/HU180234B/hu unknown
- 1979-06-28 SU SU792782749A patent/SU1360586A3/ru active
- 1979-06-28 BE BE1/9436A patent/BE877327A/fr not_active IP Right Cessation
- 1979-06-28 JP JP8340479A patent/JPS55100387A/ja active Granted
- 1979-06-28 CS CS794473A patent/CS227009B2/cs unknown
- 1979-06-28 CS CS824439A patent/CS237331B2/cs unknown
- 1979-06-29 PL PL1979231121A patent/PL126234B1/pl unknown
- 1979-06-29 KR KR7902146A patent/KR840002068B1/ko not_active Expired
-
1980
- 1980-12-26 SU SU803221911A patent/SU1024008A3/ru active
- 1980-12-29 SU SU803222794A patent/SU986295A3/ru active
-
1981
- 1981-01-20 AT AT0021781A patent/AT372947B/de not_active IP Right Cessation
- 1981-06-28 CS CS815158A patent/CS515881A2/cs unknown
-
1982
- 1982-05-27 HU HU821720A patent/HU190390B/hu unknown
-
1987
- 1987-02-05 JP JP62025530A patent/JPS6322073A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
SU986295A3 (ru) | 1982-12-30 |
SU1360586A3 (ru) | 1987-12-15 |
HU180234B (en) | 1983-02-28 |
CS237331B2 (en) | 1985-07-16 |
CS515881A2 (en) | 1985-09-17 |
HU190390B (en) | 1986-07-28 |
JPS55100387A (en) | 1980-07-31 |
CS443982A2 (cs) | 1984-12-14 |
KR840002068B1 (ko) | 1984-11-09 |
CS227009B2 (en) | 1984-04-16 |
BE877327A (fr) | 1979-12-28 |
JPS6322073A (ja) | 1988-01-29 |
ATA21781A (de) | 1983-04-15 |
AT372947B (de) | 1983-11-25 |
JPS6231717B2 (en, 2012) | 1987-07-09 |
KR830010076A (ko) | 1983-12-26 |
SU1024008A3 (ru) | 1983-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL122153B1 (en) | Process for preparing novel octahydropyrazolo-/3,4-g/ quinolinesnov | |
SK126893A3 (en) | Derivatives of perhydroisoindole and preparation thereof | |
KR20150028992A (ko) | 2-(5-브로모-4-(4-사이클로프로필나프탈렌-1-일)-4h-1,2,4-트리아졸-3-일티오)아세트산의 제조 | |
CZ245093A3 (en) | Novel thiopyranopyrrole derivatives and process of their preparation | |
JPS58170780A (ja) | 新規な化合物、その製法及び組成物 | |
EP0642508A1 (en) | Tricyclic quinoxalinediones as glutamate receptor antagonists | |
JP2005522441A (ja) | クロピドグレル塩酸塩の多形体及び抗トロンビン化合物としての使用 | |
WO2007100387A2 (en) | Process for preparing tadalafil | |
US4871746A (en) | N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzoyl]glutamic acid derivatives as neoplastic growth inhibitors | |
US4283401A (en) | Process for the preparation of 11-bromo-vincaminic acid ester derivatives and their use in protecting animals against cerebral hypoxy | |
JPH06504042A (ja) | 置換ベンゾフラン誘導体の製造法 | |
PL126234B1 (en) | Process for preparing novel octahydropyrazolo-/3,4-g/-quinolines | |
HK78895A (en) | Substituted 1H-imidazoles | |
US4473573A (en) | N-(2-methoxyethyl)-noroxymorphone and pharmaceutical compositions for relieving pain containing same | |
SI9012330A (en) | Carbamoyl derivatives | |
CN117736203A (zh) | 用于合成缬苯那嗪的方法 | |
JP3657985B2 (ja) | イミダゾ[5,1−c][1,4]ベンゾキサジン−1−オンのイミダゾリルアルキル誘導体およびそれらの製造法 | |
EP1140855A1 (en) | Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors | |
EP0399159A2 (de) | Chinolinderivate | |
EP0657443A1 (en) | Optically active carboxamide derivative | |
CN108586450B (zh) | 一种胆碱m受体抗结剂的重结晶纯化方法 | |
US4223146A (en) | 4,5,6,7-Tetrahydroimidazo-[4,5-c]-pyridine derivatives | |
US4355166A (en) | Quinuclidinic ester and derivatives of phenoxycarboxylic acids | |
HU179080B (en) | Process for producing new 1,4-dithiepino-square bracket-2,3-c-square bracket closed-pyrrole derivatives | |
KR830000273B1 (ko) | 옥타하이드로 피라졸로[3,4-g]퀴놀린의 제조방법 |